CME Escape Room: Putting Together Clues in HIV, CVD, T2D, and CKD: Escaping Management Mishaps

Faculty
Laura J. Waters, MD, FRCP
Laura J. Waters, MD, FRCP
Consultant Physician, Sexual Heath & HIV
Chair British HIV Association
Mortimer Market Centre
London, United Kingdom

Dr. Laura Waters is an HIV and Sexual Consultant and HIV Lead at the Mortimer Market Centre, London and an Honorary Associate Professor at the Institute of Global Health, University College London. She is the National Specialty Advisor for HIV, chairing the group that advises National Health Service England on HIV treatment, the immediate past chair of the British HIV Association (BHIVA) and Chair of the British Association of Sexual Health and HIV Patient & Public Voice panel.

Dr. Waters has led or co-authored several national guidelines. She has published and presented widely, is a trustee for The Food Chain and previously for the Terrence Higgins Trust. She teaches regularly at local, regional, and national levels, including HIV courses for University College London and the London School of Hygiene and Tropical Medicine. Laura founded The People First Charter in July 2021.

Laura J. Waters, MD, FRCP
David A. Wohl, MD
Professor of Medicine
Co-Principal Investigator, Global Infectious Disease Clinical Research Unit
Co-Director, Viral Hemorrhagic Fever Clinical Research Group and UNC Project Liberia
Institute for Global Health & Infectious Diseases
The University of North Carolina at Chapel Hill
School of Medicine
Chapel Hill, North Carolina

Dr. David Wohl is a Professor of Medicine in the Division of Infectious Diseases at the University of North Carolina (UNC), as well as Co-Principal Investigator of the Global UNC Infectious Diseases Clinical Trials Unit and Site Leader of its Chapel Hill research site. In addition, he has an active clinical practice at UNC.

Dr. Wohl is a clinical scientist with a focus on emergent infectious diseases. He has spent more than 20 years leading research into the prevention and treatment of HIV and served 2 terms as a member of the US Department of Health and Human Services Antiretroviral Guidelines Panel. Since 2014, he has been working continuously in Liberia, West Africa, conducting research with Ebola survivors to learn about chronic complications and sexual transmission of this infection and establishing the UNC Project Liberia research platform at 2 locations in the country. He and his team have extended this work to examine Lassa fever, a viral hemorrhagic fever endemic in West Africa

In 2020, he helped lead the UNC clinical and research response to COVID-19, directing a large drive-through testing site and 2 COVID-19 vaccination clinics. He served as vice chair of ACTIV-2, an international AIDS Clinical Trials Group/Operation Warp Speed trial of SARS-CoV-2 therapeutics.